Multiple Myeloma

CLINICAL_TRIALS research · 2026-01-28

Clinical Trial Update: Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency [Phase 2]

An ongoing Phase 2 clinical trial is testing induction therapy with bortezomib, isatuximab, cyclophosphamide, and dexamethasone in transplan…

CLINICAL_TRIALS research · 2026-01-28

Clinical Trial Update: Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy [Phase 3]

Phase 3 clinical trial evaluating a digital health intervention for self-management and telemonitoring in CAR-T therapy is currently recruit…

FDA label_change · 2026-01-27

FDA Approved: DARZALEX FASPRO — Supplemental Application (Janssen Biotech, Inc.)

The FDA approved a supplemental application for DARZALEX FASPRO, submitted by Janssen Biotech, Inc. The approval updates the labeling for th…

CLINICAL_TRIALS trial_result · 2026-01-27

Clinical Trial Update: Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation [Phase 2]

A Phase 2 trial evaluating propylene glycol-free melphalan HCl (EVOMELA) with fludarabine and total body irradiation-based reduced-intensity…

CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: Myeloma Registry Platform (MYRIAM)

A clinical trial entry for the Myeloma Registry Platform (MYRIAM) sponsored by iOMEDICO AG, currently recruiting participants with multiple …

CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]

A Phase 1 clinical trial is evaluating O&D-001 Injection for relapsed or refractory multiple myeloma. The study is currently recruiting.

CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

A phase 1/2 clinical trial is evaluating AZD0305 as a monotherapy or in combination with anticancer agents for relapsed/refractory multiple …

CLINICAL_TRIALS trial_result · 2026-01-26

Clinical Trial Update: Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders [EARLY_Phase 1]

An early-phase Phase 1 trial evaluating a GPRC5D-targeted CAR-T cell therapy for relapsed/refractory plasma cell disorders, with the study n…

CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments [Phase 1, Phase 2]

A phase 1/2 clinical trial evaluating belantamab mafodotin as both monotherapy and in combination therapy for multiple myeloma, currently re…

CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Memorial Sloan Kettering Cancer Center is recruiting families for genetic studies of familial lymphoproliferative disorders, including lymph…

CLINICAL_TRIALS trial_result · 2026-01-22

Clinical Trial Update: Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant [Phase 2]

A Phase 2 trial evaluating lenalidomide with or without ixazomib and dexamethasone in patients with residual multiple myeloma after donor st…

CLINICAL_TRIALS other · 2026-01-22

Clinical Trial Update: Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation [NA]

ClinicalTrials.gov study NCT05706766 evaluates prehabilitation exercise training for patients with multiple myeloma undergoing autologous st…

CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients [NA]

A recruiting clinical trial at University Hospital Heidelberg is evaluating fall risk assessment and an exercise intervention (strength and …

CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma [Phase 2]

This Phase 2 trial update reports a study of elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone for relapsed multipl…

CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Clinical trial update describing a Bristol-Myers Squibb-sponsored study to perform transgene assay testing on tumor samples from patients wh…

CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma [NA]

A clinical trial is recruiting for a novel CD19/BCMA dual-targeted CAR-T cell therapy for relapsed/refractory multiple myeloma.

CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments [Phase 1]

Clinical trial update announcing a Phase 1 study of Linvoseltamab in combination with other cancer treatments for adults with multiple myelo…

CLINICAL_TRIALS trial_result · 2026-01-21

Clinical Trial Update: Outcome of Multiple Myeloma Associated With Autoimmune Hemolytic Anemia [NA]

This clinical trial update reports the outcomes for patients with multiple myeloma associated with autoimmune hemolytic anemia.